Practice In Focus Application

MENUMENU

About
Initiatives
Events
Membership
- Become a Member
- Practice in Focus
Community
News
OPTA
Oncolytics Today
Practice Resources
Login
Register
Contact

Practice In Focus Application

Home Practice In Focus Application

[buddyforms_form form_slug=”practice-in-focus”]

Support NCODA’s Patient-Centered Initiatives

NCODA News

FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Bortezomib (Velcade) Management for Multiple Myeloma and Mantle Cell Lymphoma
AVEO Oncology Announces U.S. Commercial Availability of FOTIVDA® (tivozanib) for the Treatment of Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma Ahead of Previous Guidance

2021 Spring Forum

ONCOLYTICS TODAY SPRING 2021 ISSUE AVAILABLE NOW!

April 2021
M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30

« Mar

Contact

P.O. Box 468
Cazenovia, NY 13035

contact@ncoda.org

315-655-4640
a 501(c)(3) Organization

Passion for Patients

315-655-4640
contact@ncoda.org